scholarly journals TRENDS OF INDICATORS CHARACTERIZING THE BURDEN OF TYPE 2 DIABETES ON HEALTH CARE SYSTEMS IN UKRAINE AND SOME DEVELOPED COUNTRIES

2020 ◽  
Vol 46 (3) ◽  
Author(s):  
G. P. Mykhalchyshyn

Abstract Purpose of the study. Is to compare the epidemiological trends (2000–2017) of indicators characterizing the burden of type 2 diabetes on health care systems in Ukraine and some developed countries. Materials and methods. The trends in morbidity, prevalence, mortality, years lived with disability (YLDs), as well as disability adjusted life years (DALYs) in type 2 diabetes (per 100 thousand of population) were analyzed. Results. Over a period of 2000–2017, the incidence of type 2 diabetes in Ukraine increased by 10,4%, in Belarus – by 9,2%, in Poland – by 28,1%, in Germany – by 32,1% and in the United States – by 69,6%. Accordingly, the largest increase in the prevalence occurred in the United States (by 83,2%), Germany (by 40,0%) and Poland (by 42,6%) and the least in Ukraine (by 9,9%). The mortality rate in Ukraine as of 2017 was lower than in the USA, Poland and Germany, respectively: 4,0 against 17,4; 13,8; 20,6 per 100 thousand of population. The largest increase in YLDs and DALY occurred in the United States (by 81,0% and 45,6%), Germany (by 45,2% and 28,8%), Poland (by 41,6% and 45,4%), against the background of a slight increase in Ukraine (by 10,2% and 7,8%). Conclusions. Over a period of 2000–2017, the trends of indicators characterizing the burden of type 2 diabetes on the health care systems of Ukraine and other countries differ, which requires further analysis and clarification of this situation. Keywords: burden, incidence, prevalence, YLDs, DALY, type 2 diabetes.

2003 ◽  
Vol 17 (2) ◽  
pp. 27-48
Author(s):  
Kwangho Jung

There is a growing interest in the comparison of international health care data with the hope that such studies will enable individual systems to learn from other systems. There are, however, few rigorous comparative studies of health care systems. There is little evidence to suggest which model is to be preferred in what circumstances. This paper attempts to compare health care systems in three developed countries, including Germany, Sweden and the United States in terms of access, cost and quality. This paper suggests potential policies for population health in developed countries. They include universal health care coverage, the reduction of poverty and income inequality and the reallocation from health care expenditures to non-health care expenditures.


2010 ◽  
Vol 28 (27) ◽  
pp. 4149-4153 ◽  
Author(s):  
Scott R. Berry ◽  
Chaim M. Bell ◽  
Peter A. Ubel ◽  
William K. Evans ◽  
Eric Nadler ◽  
...  

Purpose Oncologists in the United States and Canada work in different health care systems, but physicians in both countries face challenges posed by the rising costs of cancer drugs. We compared their attitudes regarding the costs and cost-effectiveness of medications and related health policy. Methods Survey responses of a random sample of 1,355 United States and 238 Canadian medical oncologists (all outside of Québec) were compared. Results Response rate was 59%. More US oncologists (67% v 52%; P < .001) favor access to effective treatments regardless of cost, while more Canadians favor access to effective treatments only if they are cost-effective (75% v 58%; P < .001). Most (84% US, 80% Canadian) oncologists state that patient out-of-pocket costs influence their treatment recommendations, but less than half the respondents always or frequently discuss the costs of treatments with their patients. The majority of oncologists favor more use of cost-effectiveness data in coverage decisions (80% US, 69% Canadian; P = .004), but fewer than half the oncologists in both countries feel well equipped to use cost-effectiveness information. Majorities of oncologists favor government price controls (57% US, 68% Canadian; P = .01), but less than half favor more cost-sharing by patients (29% US, 41% Canadian; P = .004). Oncologists in both countries prefer to have physicians and nonprofit agencies determine whether drugs provide good value. Conclusion Oncologists in the United States and Canada generally have similar attitudes regarding cancer drug costs, cost-effectiveness, and associated policies, despite practicing in different health care systems. The results support providing education to help oncologists in both countries use cost-effectiveness information and discuss drug costs with their patients.


2015 ◽  
Vol 10 (1) ◽  
pp. 161-164 ◽  
Author(s):  
John Walsh ◽  
Allan Graeme Swan

ABSTRACTThe process for developing national emergency management strategies for both the United States and the United Kingdom has led to the formulation of differing approaches to meet similar desired outcomes. Historically, the pathways for each are the result of the enactment of legislation in response to a significant event or a series of events. The resulting laws attempt to revise practices and policies leading to more effective and efficient management in preparing, responding, and mitigating all types of natural, manmade, and technological hazards. Following the turn of the 21st century, each country has experienced significant advancements in emergency management including the formation and utilization of 2 distinct models: health care coalitions in the United States and resiliency forums in the United Kingdom. Both models have evolved from circumstances and governance unique to each country. Further in-depth study of both approaches will identify strengths, weaknesses, and existing gaps to meet continued and future challenges of our respective disaster health care systems. (Disaster Med Public Health Preparedness. 2016;10:161–164)


Sign in / Sign up

Export Citation Format

Share Document